Literature DB >> 17050681

Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory.

Pamela Maher1, Tatsuhiro Akaishi, Kazuho Abe.   

Abstract

Small molecules that activate signaling pathways used by neurotrophic factors could be useful for treating CNS disorders. Here we show that the flavonoid fisetin activates ERK and induces cAMP response element-binding protein (CREB) phosphorylation in rat hippocampal slices, facilitates long-term potentiation in rat hippocampal slices, and enhances object recognition in mice. Together, these data demonstrate that the natural product fisetin can facilitate long-term memory, and therefore it may be useful for treating patients with memory disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050681      PMCID: PMC1637622          DOI: 10.1073/pnas.0607822103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Memory enhancement: the search for mechanism-based drugs.

Authors:  Gary Lynch
Journal:  Nat Neurosci       Date:  2002-11       Impact factor: 24.884

2.  Fisetin induces transcription of NADPH:quinone oxidoreductase gene through an antioxidant responsive element-involved activation.

Authors:  D X Hou; M Fukuda; J A Johnson; K Miyamori; M Ushikai; M Fujii
Journal:  Int J Oncol       Date:  2001-06       Impact factor: 5.650

Review 3.  Molecular psychology: roles for the ERK MAP kinase cascade in memory.

Authors:  J Paige Adams; J David Sweatt
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

Review 4.  Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications.

Authors:  F V DeFeudis; K Drieu
Journal:  Curr Drug Targets       Date:  2000-07       Impact factor: 3.465

5.  Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms.

Authors:  K Ishige; D Schubert; Y Sagara
Journal:  Free Radic Biol Med       Date:  2001-02-15       Impact factor: 7.376

6.  Dietary ortho phenols that induce glutathione S-transferase and increase the resistance of cells to hydrogen peroxide are potential cancer chemopreventives that act by two mechanisms: the alleviation of oxidative stress and the detoxification of mutagenic xenobiotics.

Authors:  H Fiander; H Schneider
Journal:  Cancer Lett       Date:  2000-08-11       Impact factor: 8.679

Review 7.  Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.

Authors:  F Fumagalli; G Racagni; M A Riva
Journal:  Pharmacogenomics J       Date:  2006 Mar-Apr       Impact factor: 3.550

Review 8.  Update on the therapeutic potential of PDE4 inhibitors.

Authors:  Hazel J Dyke; John G Montana
Journal:  Expert Opin Investig Drugs       Date:  2002-01       Impact factor: 6.206

Review 9.  Neurobehavioral effects of dietary soy phytoestrogens.

Authors:  Edwin D Lephart; Timothy W West; K Scott Weber; Reuben W Rhees; Kenneth D R Setchell; Herman Adlercreutz; Trent D Lund
Journal:  Neurotoxicol Teratol       Date:  2002 Jan-Feb       Impact factor: 3.763

10.  Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat.

Authors:  J Prickaerts; W C G van Staveren; A Sik; M Markerink-van Ittersum; U Niewöhner; F J van der Staay; A Blokland; J de Vente
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

View more
  88 in total

1.  Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning.

Authors:  Tessi Sherrin; Thomas Blank; Cathrin Hippel; Martin Rayner; Roger J Davis; Cedomir Todorovic
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

2.  A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect.

Authors:  Xia Liu; Chi-Bun Chan; Sung-Wuk Jang; Sompol Pradoldej; Junjian Huang; Kunyan He; Lien H Phun; Stefan France; Ge Xiao; Yonghui Jia; Hongbo R Luo; Keqiang Ye
Journal:  J Med Chem       Date:  2010-11-12       Impact factor: 7.446

3.  Cell and brain tissue imaging of the flavonoid fisetin using label-free two-photon microscopy.

Authors:  Tatiana B Krasieva; Jennifer Ehren; Thomas O'Sullivan; Bruce J Tromberg; Pamela Maher
Journal:  Neurochem Int       Date:  2015-08-10       Impact factor: 3.921

Review 4.  Neurotrophic natural products: chemistry and biology.

Authors:  Jing Xu; Michelle H Lacoske; Emmanuel A Theodorakis
Journal:  Angew Chem Int Ed Engl       Date:  2013-12-18       Impact factor: 15.336

5.  Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations.

Authors:  Sebastian Schaffer; Barry Halliwell
Journal:  Genes Nutr       Date:  2011-10-20       Impact factor: 5.523

Review 6.  Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.

Authors:  Filipa I Baptista; Ana G Henriques; Artur M S Silva; Jens Wiltfang; Odete A B da Cruz e Silva
Journal:  ACS Chem Neurosci       Date:  2014-01-03       Impact factor: 4.418

7.  A novel approach to screening for new neuroprotective compounds for the treatment of stroke.

Authors:  Pamela Maher; Karmen F Salgado; Justin A Zivin; Paul A Lapchak
Journal:  Brain Res       Date:  2007-08-09       Impact factor: 3.252

8.  Quercetin relieves chronic lead exposure-induced impairment of synaptic plasticity in rat dentate gyrus in vivo.

Authors:  Pu Hu; Ming Wang; Wei-Heng Chen; Ji Liu; Liang Chen; Shu-Ting Yin; Wu Yong; Ju-Tao Chen; Hui-Li Wang; Di-Yun Ruan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-06       Impact factor: 3.000

9.  Tanshinone I enhances learning and memory, and ameliorates memory impairment in mice via the extracellular signal-regulated kinase signalling pathway.

Authors:  Dong Hyun Kim; Sunho Kim; Su Jin Jeon; Kun Ho Son; Seungjoo Lee; Byung Hoon Yoon; Jae Hoon Cheong; Kwang Ho Ko; Jong Hoon Ryu
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

Review 10.  Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management.

Authors:  Vaqar Mustafa Adhami; Deeba Nadeem Syed; Naghma Khan; Hasan Mukhtar
Journal:  Biochem Pharmacol       Date:  2012-07-25       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.